Friday, 23 December 2011

2.2) Item Descriptor

An item descriptor implements the atg.repository.RepositoryItemDescriptor interface and can subclass atg.repository.ItemDescriptorImpl. An item descriptor provides the following information:
2.1) Repository Items:

  • A repository is a collection of repository items. A repository item is a JavaBean component

Repository API

2) Repository API

  • The ATG Repository API (atg.repository.*) is the foundation of persistent object storage, user profiling, and content targeting in ATG products.
1) Introduction

Data access is a large part of most Internet applications.

ATG Data Anywhere Architecture™ provides a unified view of content and data across a business for organizations and their customers. The core of the ATG Data Anywhere Architecture is the Repository API.


Tuesday, 20 December 2011

SYNDROMES


 This is collection of most of the syndromes,
ENVIRONMENTAL CAUSES
• ACUTE RADIATION SYNDROME: Radiation
exposure.
o 12 hours post-exposure: Vomiting
o 24 hours post-exposure: Prostration (extreme
exhaustion), fever, diarrhea
o Later: Petechial hemorrhage, hypotension,
tachycardia, profuse bloody diarrhea, maybe
death.

Easy to remember

click on topics to view ,



Pharmacology




Pulmonary infiltrations inducing drugs "Go BAN Me!": 
Gold 
Bleomycin/ Busulphan/ BCNU 
Amiodarone/ Acyclovir/ Azathioprine 
Nitrofurantoin 
Melphalan/ Methotrexate/ Methysergide

CNS


Bell's palsy: symptoms Hi Yield [ID 1943]
BELL'S Palsy:
Blink reflex abnormal
Earache
Lacrimation [deficient, excess]
Loss of taste
Sudden onset
Palsy of VII nerve muscles
_ All symptoms are unilateral.
Knowledge Level 4, System: Nervous
Robert O'Connor University College Dublin

Saturday, 17 December 2011

Medical Videos Categories

click on topics to view,


  1. CVS
  2. RS 
  3. GIT 
  4. CNS 
  5. Renal 
  6. Bone 
  7. Ear 
  8. Eye 
  9. Inflammation & Repair 
  10. Hormones 
  11. Immunity 
  12. Liver 
  13. Bone Marrow 
  14. Skin 



Body Story-The bones and the skeleton (3 of 3)

Body Story-The bones and the skeleton (2 of 3)

Body Story-The bones and the skeleton (1 of 3)

Body Story-The eye (3 of 3)

Body Story-The eye (2 of 3)

Body Story-The eye (1 of 3)

Body Story-The ear (3 of 3)

Body Story-The ear (2 of 3)

Body Story-The ear (1 of 3)

Body Story-The lymphatic system (3 of 3)

Body Story-The lymphatic system (2 of 3)

Body Story-The lymphatic system (1 of 3)

Body Story-The skin (3 of 3)

Body Story-The skin (2 of 3)

Body Story-The skin (1 of 3)

Body Story-The neurones (3 of 3)

Body Story-The neurones (2 of 3)

Body Story-The neurones (1 of 3)

Body Story-Repairs and changes (3 of 3)

Body Story-Repairs and changes (2 of 3)

Body Story-Repairs and changes (1 of 3)

Body Story-The brain (3 of 3)

Body Story-The brain (2 of 3)

Body Story-The brain (1 of 3)

Body Story-The kidneys (3 of 3)

Body Story-The kidneys (2 of 3)

Body Story-The kidneys (1 of 3)

Body Story-The liver factory (3 of 3)

Body Story-The liver factory (2 of 3)

Body Story-The liver factory (1 of 3)

Body Story-The digestion (3 of 3)

Body Story-The digestion (2 of 3)

Body Story-The digestion (1 of 3)

Body Story-Breathing (3 of 3)

Body Story-Breathing (2 of 3)

Body Story-Breathing (1 of 3)

Body Story-The heart (3 of 3)

Body Story-The heart (2 of 3)

Body Story-The heart (1 of 3)

Body Story-Hormones(2)

Body Story-Hormones(3)

Body Story-Hormone(1)

Body Story-The blood (3 of 3)

Body Story-The bone marrow (1 of 3)

Body Story-The bone marrow (2)

Body Story-The blood (2 of 3)

Body Story-The bone marrow (3 of 3)

Body Story-The blood (1 of 3)

Pericarditis

Kidney and Nephron

Monday, 12 December 2011

Patty's Toxicology

Patty's Toxicology

General Principles of Pharmacology

General Principles of Pharmacology

ModPharmacClinApp6thEd

ModPharmacClinApp6thEd

Pharmacology in Critically Ill

Pharmacology in Critically Ill

Pharmacotherapy

Pharmacotherapy

Psychiatric Drugs-Lawrence,rhoda

Psychiatric Drugs

Medical Pharmacology at a Glance-Michael J.Neal

Medical Pharmacology at a Glance

Goodman Gilman Pharmacology part -17

Section 16. Toxicology

Goodman Gilman Pharmacology part -16

Section 15. Ophthalmology

Goodman Gilman Pharmacology part -15

Section 14. Dermatology

Goodman Gilman Pharmacology part -14

Section 13. the Vitamins

Goodman Gilman Pharmacology part -13

Section 12. Hormones and Hormone Antagonists

Goodman Gilman Pharmacology part -12

Section 11. Drugs Acting on the Blood and the Blood-Forming Organs

Goodman Gilman Pharmacology part -11

Section 10. Drugs Used for Immunomodulation

Goodman Gilman Pharmacology part -10

Section 9. Chemotherapy of Neoplastic Diseases

Goodman Gilman Pharmacology part -9

Section 8. Chemotherapy of Microbial Diseases

Goodman Gilman Pharmacology part -8

Section 6. Drugs Affecting Gastrointestinal Function

Goodman Gilman Pharmacology part -7

Section 5. Drugs Affecting Renal and Cardiovascular Function

Goodman Gilman Pharmacology part -6

Section 4. Autacoids Drug Therapy of Inflammation

Goodman Gilman Pharmacology part -5

Section 3. Drugs Acting on the Central Nervous System

Goodman Gilman Pharmacology part -5

Section 3. Drugs Acting on the Central Nervous System

Goodman Gilman Pharmacology part -4

Section 2. Drugs Acting at Synaptic and Neuroeffector Junctional Sites

Goodman Gilman Pharmacology part -3

Section 1. General Principles

Goodman Gilman Pharmacology part -2

Appendix II Design and Optimization of Dosage Regimens Pharmacokinetic Data

Goodman Gilman Pharmacology part -1

Appendix I Principles of Prescription Order Writing and Patient Compliance

ACLS

acls

Critical Care Medicine

Critical Care Medicine

Handbook of Anesthesiology

Anesthesiology

History and Physical Exam

History and Physical Exam

Gynecology and Obstetrics

Gynecology and Obstetrics

Outpatient Medicine

Outpatient Medicine

Medicine

Medicine

Pediatric Drug Reference

Pediatric Drug Reference

Pediatric Treatment

Pediatric Treatment

Pediatrics

Pediatrics

Physicians Drug Resource

Physicians Drug Resource

Psychiatry

Psychiatry

Psychiatric Drugs

Psychiatric Drugs

Surgery

Surgery

Treatment Guidelines

Treatment Guidelines








Topics

HIV AIDS strategies

Manual of Hiv Aids

Perils of Paranoia

Dead and Buried

Thursday, 8 December 2011

Manipal Application

Profile Repository Caching

  • A SQL profile repository, can maintain repository items in item caches
  • Strongly recommended that you do not use locked caching for the user item in the profile repository
    The user items in both the ProfileAdapterRepository and the InternalProfileRepository are configured to use simple cache mode
  • Caching is disabled for the Password property in both repositories

Standard User Profile Repository Definition

Profile Repository Administration Interfaces

Three interfaces to view/edit profile repository items:

1) The ATG Dynamo Server Admin interface (http://hostname:port/dyn/admin/nucleus)
2) The Personalization > Users options in the ATG Business Control Center
3) The Profile Repository window in the ACC

Internal and External user profiles

ATG maintains separate profile repositories for external and internal users.
  • External user profiles represent anyone who visits your externally-facing Web site. For commerce sites, external users are typically customers.The default external user profile repository is /atg/userprofiling/ProfileAdapterRepository, which is defined by the userProfile.xml file located in <ATG9dir>\DPS\config\profile.jar.
  • Internal user profiles represent people within your organization who use ATG applications such as the ATG Business Control Center or ATG Service to create and manage site content.Internal profiles are stored in the /atg/userprofiling/InternalProfileRepository, defined by the internalUserProfile.xml file in <ATG9dir>\DPS\InternalUsers\config\config.jar.


ATG Personalization Programming

Profile Repository
  • ATG applications use profile repositories to manage user profiles.
  • A standard profile repository is a SQL repository component of class atg.adapter.gsa.GSARepository. 
  • Each user profile is represented by an item in the profile repository, and the attributes that make up the profile are stored as properties of the repository item. A profile repository definition is a list of all the profile properties that you want to track for users. For example, you can define a profile repository to track the first name, last name, and address for site members. 
  • The standard profile repository definition is located in the configuration path at /atg/userprofiling/userProfile.xml.

ATG - Create a Website of your own

Art Technology Group (ATG) was an independent Internet technology company specializing in eCommerce software and on-demand optimization applications until its acquisition by Oracle on January 5, 2011. ATG continues to be based in Cambridge, Massachusetts and operates under its own name as a subsidiary of Oracle.


Wednesday, 7 December 2011

house S8E03

House S08E01

house S8E02

house S8E04

House S08E06 Parents

HOUSE MD

starting a house serial eighth season,

Medical TV Serials

UPDATES IN HARRISON 18TH EDITION

Management protocol for bird flu cases

When to suspect:


Patents presenting with Fever (body temperature of 38o Celsius or high) with one of the following symptoms:


Muscle ache, cough, abnormal breathing (unusual breathing difficulty) or suspected pneumonia by the physician, or influenza


in addition to


History of direct contact with infected / dead birds in past 7 days or


Occurrence of unusual death of birds in the community within the past 14 days; or


Contact with a pneumonia patient or another patient suspected of avian influenza


 


Case definition of probable case: symptoms of suspected case and

Preliminary test shows infection of influenza group A, but cannot yet be confirmed whether it is from human or birds or


Respiratory failure or


Death


 


Case definition of Confirmed cases: A suspected or probable case with at least one of the following:


•     Positive viral culture for influenza A/H5


•     Positive RT PCR for influenza A/H5


•     Positive IFA for influenza A/H5


•     A 4 fold rise in influenza A/H5 specific antibody titers.


 


Management guideline for all suspected cases of avian flu:


Obtain NP swabs from all the patients (see annexure 1)


Assess severity of illness: Look for presence of following:


Respiratory distress as indicated by: increased respiratory rates, chest indrawing, dehydration, hypotension, altered sensorium or oxygen saturation of less than 93% in room air. If any of these are present patient should be admitted to ward in designated area and manage on following principles


1.      Isolate cases


Monitor vital signs every 1-2 hours

 Maintain air way breathing and circulation (ABC)

 Maintain hydration, electrolyte balance, and nutrition

 Provide oxygen and assisted ventilation when indicated

 Manage fever with paracetamol

Give antiviral Oseltamivir (For doses see annexure 2)

 Broad spectrum antibiotics for treatment of secondary pulmonary infection

 Avoid giving nebulized medications: chances of spread




Management of non severe cases


If patient is stable: (absence of above clinical features): take NP aspirate from all the patients and isolate them in the designated area identified for them and Start on Oseltamivir


 


Obtain lab results and see clinical course. If lab tests negative: discontinue Oseltamivir and provide supportive care, shift them to regular wards if hospitalization indicated otherwise send them home


 


If lab test is positive: Transfer to designated in patient area and continue supportive care and oseltamivir



Discharge policy


Adult patients: Infection control precautions for 7 days after resolution of fever


Children: Infection control measures for 21 days after onset of illness.


If discharged earlier: child should not attend school and parents should be educated to observe infection control measures at home.


 


Precautions for health care workers handling cases of avian flu


Wear personal protective equipments


 


A.     Protective clothings:


1.      Overall plus an impermeable apron or surgical gown with long cuffed sleeves plus impermeable apron


2. Heavy duty rubber work gloves that may be disinfected


3. Standard well fitted surgical masks should be used if N 95 respiratory masks are not available.


4. Goggles


5.     Rubber or polyurethane boots or protective foot cover


 


B .Chemoprophylaxis:


For close contacts: Oseltamivir 75 mg daily for 7 days


Persons at risk: Oseltamivir 75 mg daily for the entire epidemic


 


C.    Monitoring of close contacts and health care workers exposed: observe for fever of >38 Celsius, watery diarrhoea, pain abdomen, headache, cough, rhinorrhoea, sore throat, shortness of breath and CNS manifestations. Check for them daily till 14 days of last exposure 



 


Annexure 1

Collection and transport of samples

Samples from upper respiratory tract include

Nsopharyngeal aspirate

 Nasal wash

 Throat swab

From lower respiratory tract samples include :

Transtracheal aspirate

 Bronchoalveolar lavage

 Lung biopsy

 Post-mortem lung or tracheal tissue

Specimens for the laboratory diagnosis of avian influenza A should be collected in the following order of priority:

·        nasopharyngeal aspirate/swab

·        acute serum

·        convalescent serum.

The sample collection should be done with all the necessary biosafety precautions including use of gowns, gloves and masks

The samples should be kept on ice and transported to virology laboratory as soon as possible


Annexure II


Antiviral drugs and their doses


Oseltamivir: is the only drug effective against H5N1 virus Doses are:


•         Adults: 75 mg twice a day for adults,


•         Children weighing < 15 Kg: 30 mg twice a day


15-23 Kgs: 45 mg twice a day

 23-40 kgs: 60 mg twice a day


                                       > 40 kg: 75 mg twice a day


Adverse effects of oseltamivir


Nausea and vomiting: transient and occur in the beginning and are self limiting


Abdominal pain, epistaxis, conjuctivitis


Should be used in pregnancy with caution


 


Contraindications: Hypersensitivity to drug


 


 


Algorithm for management of Avian flu patients


                                               

Suspect case of Avian flu


 (Patents presenting with Fever (body temperature of 38o Celsius or high) with one of the following symptoms: Muscle ache, cough, abnormal breathing (unusual breathing difficulty) or suspected pneumonia by the physician, or influenza in addition to History of direct contact with infected / dead birds in past 7 days or  Occurrence of unusual death of birds in the community within the past 14 days; or Contact with a pneumonia patient or another patient suspected of avian influenza)


 


Obtain NP aspirates and send to lab





  

Asses severity of illness

(Look for presence of following Respiratory distress as indicated by: increased respiratory rates, chest indrawing, dehydration, hypotension, altered sensorium or oxygen saturation of less than 93% in room air)





 






Any one of the above present                                                    None of the above present

                                                                                   

Admit in designated area and treat as follows


Isolate cases


Monitor vital signs every 1-2 hours

Maintain air way breathing and circulation (ABC)

Maintain hydration, electrolyte balance, and nutrition

Provide oxygen and assisted ventilation when indicated

Manage fever with paracetamol

Give antiviral Oseltamivir (For doses see annexure 2)

Broad spectrum antibiotics for treatment of secondary pulmonary infection

Avoid giving nebulized medications: chances of spread

 

                                                                                                                       















Keep the patient in designated out patient area, start oseltamivir and collect lab report reportresults

 



















Transfer to general ward and manage according to 

 



Send home with supportive care